Fact-check
Is Patanjali banned in India?
Last checked 10 October 2026
No Patanjali or Divya Pharmacy product is banned nationally: Uttarakhand suspended 14 product licences on 15 Apr 2024 and, as reported, cancelled that suspension on 1 Jul 2024; the Supreme Court closed its case on 11 Aug 2025; Maharashtra's Jun 2026 seizures are an advertising matter.
- Classification
- No ban or recall found in official records
- Decided by
- Supreme Court of India; Uttarakhand State Licensing Authority; Maharashtra Food and Drug Administration
- Reference
- Indian Medical Association v Union of India, W.P.(C) 645/2022; Uttarakhand suspension of 15 Apr 2024 under Rule 159(1); Maharashtra FDA seizures of Jun 2026 under the DMR Act
- Latest action
- 6 November 2025
- Last checked
- 10 October 2026
Photo: An Ayurvedic Pharmacy, Rishikesh (1).jpg by Ken Wieland from Philadelphia, USA (CC BY-SA 2.0). All photo credits.
Maharashtra FDA: not of standard quality (NSQ) alerts table
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Status today
- No Patanjali or Divya Pharmacy product is banned nationally
- 2024 suspensions
- 15 Apr 2024: Uttarakhand State Licensing Authority suspended the manufacturing licences of 14 products under Rule 159(1) for repeated misleading advertising; the state cancelled that suspension on 1 Jul 2024 (reported)
- Supreme Court
- Indian Medical Association v Union of India, W.P.(C) 645/2022: petition disposed of on 11 Aug 2025
- Maharashtra, Jun 2026
- About Rs 51 lakh of Divya Pharmacy products seized under the DMR Act for 'miraculous cure' claims; Patanjali moved the Bombay High Court; the state said it would take no coercive action for the time being
- Lab test
- One Divya Pharmacy product, Arjuna Kwath, appears in Maharashtra FDA's NSQ table for microbial limit
Where the claim comes from
Headlines in April 2024 said Patanjali licences were 'revoked' after Uttarakhand suspended 14 products, and the Supreme Court hearings of 2022 to 2025 were widely reported as action against the brand. A suspension of named products is not a ban on the brand.
Nothing made by Patanjali Ayurved or Divya Pharmacy is banned nationally. Four separate matters are often reported as bans: a 2024 licence suspension in Uttarakhand, a Supreme Court case on misleading advertising that ran from 2022 to 2025, a 2026 seizure of Divya Pharmacy products in Maharashtra, and one failed lab test. None of them is a ban on the brand.
On 15 Apr 2024 the Uttarakhand State Licensing Authority (Ayurveda and Unani) suspended the manufacturing licences of 14 products of Divya Pharmacy and Patanjali Ayurved under Rule 159(1), for repeated misleading advertising. The products were Swasari Gold, Swasari Vati, Bronchom, Swasari Pravahi, Swasari Avaleh, Mukta Vati Extra Power, Lipidom, BP Grit, Madhugrit, Madhunashini Vati Extra Power, Livamrit Advance, Livogrit, Eyegrit Gold and Patanjali Drishti Eye Drop. Patanjali told the Supreme Court on 9 Jul 2024 that it had stopped selling them and had told 5,606 franchise stores to withdraw them. Business Standard reported on 31 Jul 2024 that the state had cancelled the suspension order on 1 Jul 2024 after a committee report, with a fresh decision pending, and that at the hearing of 30 Jul 2024 the court asked Uttarakhand to decide the matter and report in two weeks. No later order is on public record. One April 2024 headline said the licences were revoked; the body of that report said suspended.
The Supreme Court case is Indian Medical Association v Union of India, W.P.(C) 645/2022. Contempt proceedings against Ramdev and Balkrishna over misleading advertisements were closed after apologies in Aug 2024. On 11 Aug 2025 a bench of Justices Nagarathna and Viswanathan vacated its stay on the omission of Rule 170 and disposed of the petition, leaving parties free to challenge the omission separately. A criminal case over the advertisements was reported to have been quashed by the High Court at Nainital in Jun 2025.
In Jun 2026 Maharashtra FDA seized about Rs 51 lakh of Divya Pharmacy products (Drushti Eye Drop, Giloy Ghan Vati, Kutaj Ghan Vati, Cystogrit Diamond and Neurogrit Gold) for 'miraculous cure' claims under the Drugs and Magic Remedies Act. Patanjali moved the Bombay High Court and the state told the court it would take no coercive action for the time being. Separately, Maharashtra FDA's table of products that failed state lab tests lists one Divya Pharmacy product, Arjuna Kwath, for microbial limit. That is one finding, not a finding about the brand. Food products fall under food law and are not covered on this page.
What this means for you
Suspended is not banned
A licence suspension stops manufacture of the named products while it stands. The 2024 suspension covered 14 products and was cancelled by the state on 1 Jul 2024 (reported). No later order is on public record.
A seizure is not a ban
The Jun 2026 Maharashtra seizures were made under the Drugs and Magic Remedies Act, which governs advertising claims. They are before the Bombay High Court, and the state said it would take no coercive action for the time being.
Look up the exact product
Orders name products, not the whole brand. For the three events and the one failed lab test on record, see the linked pages below.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Common questions
Is Patanjali Madhunashini banned?
No national ban is on record. Madhunashini Vati Extra Power was one of the 14 products whose manufacturing licences Uttarakhand suspended on 15 Apr 2024. The state is reported to have cancelled that suspension on 1 Jul 2024.
Is Patanjali banned in other countries?
No ban is on record. See 'Is Patanjali banned in Nepal, the USA or Dubai?' for what is and is not on record abroad.
Official sources and primary records
- Maharashtra FDA: not of standard quality (NSQ) alerts tableRegulatorMaharashtra Food and Drug Administration · 9 October 2026
- Supreme Court vacates stay on AYUSH Ministry's notification that permitted advertisements of ayurvedic, unani, siddha drugsNewsLiveLaw · 11 August 2025
- News
- Patanjali licence suspended: 14 Patanjali and Divya Pharmacy products, Uttarakhand authority tells Supreme CourtNewsOnmanorama · 30 April 2024
- Licences of 14 Patanjali drugs revoked, Uttarakhand State Licensing Authority tells Supreme CourtNewsScroll.in · 30 April 2024
- Stopped sale of 14 products whose manufacturing licences were suspended, Patanjali tells SCNewsThe Week · 9 July 2024
- SC asks Uttarakhand govt to decide on suspension of 14 Patanjali productsNewsBusiness Standard · 31 July 2024
- News
- News
- Source
- Del HC grants interim relief in Dabur v Patanjali chyawanprash caseNewsSCC Online · 12 November 2025